Abstract

Psoriatic arthritis (PsA) is an inflammatory condition characterized by a strong heterogeneity and multifaceted behavior. PsA manifests in two types—axial and peripheral—which may be present at the same time. Peripheral manifestations can be further divided into the articular (arthritis) and extra-articular (i.e., enthesitis and dactylitis) subgroups. In such a complex disease, imaging is often required to characterize the type of involvement and to evaluate the radiological damage and progression of PsA. In addition, imaging plays a pivotal role in clinical practice; that is, for axial involvement. Conventional radiology has been the main standard of reference for many years. However, in recent years, there has been growing interest in different imaging modalities, such as ultrasonography (US) and magnetic resonance imaging (MRI). All these techniques play a role in the diagnosis and follow-up of patients with PsA and cover all the types of the disease. US and MRI have good sensitivities and specificities for detecting synovitis, and this may be helpful for differential diagnosis with other musculoskeletal diseases and useful in the early or preclinical phases of the disease. However, US is not useful in the diagnosis of axial PsA. In addition, other modalities have been investigated in the field of PsA imaging. Computed tomography (CT), in particular, dual energy-CT and high-resolution peripheral CT (HRpQ-CT) might play an important role in the assessment of bone damage, erosions, and new bone formation. Regarding advanced functional imaging, FDG PET/CT is another interesting technique for exploring disease activity.

Highlights

  • Psoriatic arthritis (PsA) is characterized by a wide spectrum of features and can express itself as part of the psoriatic disease [1]

  • The increase in the total modified Sharp/Van der Heijde score results was strongly associated with higher values of Health Assessment Questionnaire (HAQ), for both joint space narrowing and erosions, but the latter was less determinant for disability even though the comparison with the remission group showed a strong significance (p < 0.0001)

  • A study investigating psoriatic arthritis (PsA) patients under IL-17 inhibition with secukinumab showed a significant decrease in power Doppler (PD) US signs of joint inflammation after 24 weeks of treatment in good agreement with significant changes in magnetic resonance imaging (MRI)-detected synovitis as well as clinical measures of joint diseases such as Disease Activity for Psoriatic Arthritis (DAPSA) and DAS28-ESR [36]

Read more

Summary

Frontiers in Medicine

Peripheral manifestations can be further divided into the articular (arthritis) and extra-articular (i.e., enthesitis and dactylitis) subgroups. In such a complex disease, imaging is often required to characterize the type of involvement and to evaluate the radiological damage and progression of PsA. In recent years, there has been growing interest in different imaging modalities, such as ultrasonography (US) and magnetic resonance imaging (MRI). All these techniques play a role in the diagnosis and follow-up of patients with PsA and cover all the types of the disease.

INTRODUCTION
MRI IN PERIPHERAL ARTHRITIS
First Author
Comparison MRI and US
Ultrasonography and monitoring in PsA
MSUS can monitor articular and periarticular response to apremilast in PsA
MRI AND AXIAL INVOLVEMENT
NOVEL TECHNIQUES
MRI and axial involvement in PsA
CONCLUSIONS
Future perspectives
Findings
Extreme structural detail
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call